Skip to main content
Top
Published in: Diabetologia 1/2015

01-01-2015 | For Debate

The time has come to test the beta cell preserving effects of exercise in patients with new onset type 1 diabetes

Authors: Parth Narendran, Thomas P. Solomon, Amy Kennedy, Myriam Chimen, Rob C. Andrews

Published in: Diabetologia | Issue 1/2015

Login to get access

Abstract

Type 1 diabetes is characterised by immune-mediated destruction of insulin-producing beta cells. Significant beta cell function is usually present at the time of diagnosis with type 1 diabetes, and preservation of this function has important clinical benefits. The last 30 years have seen a number of largely unsuccessful trials for beta cell preservation, some of which have been of therapies that have potential for significant harm. There is a need to explore new, more tolerable approaches to preserving beta cell function that can be implemented on a large clinical scale. Here we review the evidence for physical exercise as a therapy for the preservation of beta cell function in patients with newly diagnosed type 1 diabetes. We highlight possible mechanisms by which exercise could preserve beta cell function and then present evidence from other models of diabetes that demonstrate that exercise preserves beta cell function. We conclude by proposing that there is now a need for studies to explore whether exercise can preserve beta cell in patients newly diagnosed with type 1 diabetes.
Literature
1.
go back to reference Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221–229PubMedCrossRef Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221–229PubMedCrossRef
2.
go back to reference Sherry NA, Tsai EB, Herold KC (2005) Natural history of beta-cell function in type 1 diabetes. Diabetes 54(Suppl 2):S32–S39PubMedCrossRef Sherry NA, Tsai EB, Herold KC (2005) Natural history of beta-cell function in type 1 diabetes. Diabetes 54(Suppl 2):S32–S39PubMedCrossRef
3.
go back to reference Oram RA, Jones AG, Besser REJ et al (2014) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57:187–191PubMedCentralPubMedCrossRef Oram RA, Jones AG, Besser REJ et al (2014) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57:187–191PubMedCentralPubMedCrossRef
4.
go back to reference Steffes MW, Sibley S, Jackson M, Thomas W (2003) Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26:832–836PubMedCrossRef Steffes MW, Sibley S, Jackson M, Thomas W (2003) Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26:832–836PubMedCrossRef
5.
6.
go back to reference Kroll JL, Beam C, Li S et al (2013) Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes. J Clin Virol 57:115–119PubMedCentralPubMedCrossRef Kroll JL, Beam C, Li S et al (2013) Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes. J Clin Virol 57:115–119PubMedCentralPubMedCrossRef
7.
go back to reference Keymeulen B, Candon S, Fafi-Kremer S et al (2010) Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood 115:1145–1155PubMedCrossRef Keymeulen B, Candon S, Fafi-Kremer S et al (2010) Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood 115:1145–1155PubMedCrossRef
9.
go back to reference Nielsen JH, Linde S, Welinder BS et al (1989) Growth hormone is a growth factor for the differentiated pancreatic beta-cell. Mol Endocrinol 3:165–173PubMedCrossRef Nielsen JH, Linde S, Welinder BS et al (1989) Growth hormone is a growth factor for the differentiated pancreatic beta-cell. Mol Endocrinol 3:165–173PubMedCrossRef
10.
go back to reference Jensen J, Galsgaard ED, Karlsen AE et al (2005) STAT5 activation by human GH protects insulin-producing cells against interleukin-1β, interferon-γ and tumour necrosis factor-α-induced apoptosis independent of nitric oxide production. J Endocrinol 187:25–36PubMedCrossRef Jensen J, Galsgaard ED, Karlsen AE et al (2005) STAT5 activation by human GH protects insulin-producing cells against interleukin-1β, interferon-γ and tumour necrosis factor-α-induced apoptosis independent of nitric oxide production. J Endocrinol 187:25–36PubMedCrossRef
11.
go back to reference Choi SB, Jang JS, Hong SM et al (2006) Exercise and dexamethasone oppositely modulate beta-cell function and survival via independent pathways in 90% pancreatectomized rats. J Endocrinol 190:471–482PubMedCrossRef Choi SB, Jang JS, Hong SM et al (2006) Exercise and dexamethasone oppositely modulate beta-cell function and survival via independent pathways in 90% pancreatectomized rats. J Endocrinol 190:471–482PubMedCrossRef
12.
go back to reference Park S, Hong SM, Lee JE, Sung SR (2007) Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic beta-cell function and mass through IRS2 in diabetic rats. J Appl Physiol 103:1764–1771PubMedCrossRef Park S, Hong SM, Lee JE, Sung SR (2007) Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic beta-cell function and mass through IRS2 in diabetic rats. J Appl Physiol 103:1764–1771PubMedCrossRef
13.
go back to reference Ellingsgaard H, Hauselmann I, Schuler B et al (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17:1481–1489PubMedCrossRef Ellingsgaard H, Hauselmann I, Schuler B et al (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17:1481–1489PubMedCrossRef
14.
go back to reference Ronsen O, Lea T, Bahr R, Pedersen BK (2002) Enhanced plasma IL-6 and IL-1ra responses to repeated vs. single bouts of prolonged cycling in elite athletes. J Appl Physiol (1985) 92:2547–2553 Ronsen O, Lea T, Bahr R, Pedersen BK (2002) Enhanced plasma IL-6 and IL-1ra responses to repeated vs. single bouts of prolonged cycling in elite athletes. J Appl Physiol (1985) 92:2547–2553
15.
go back to reference Steensberg A, Fischer CP, Keller C et al (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285:E433–E437PubMed Steensberg A, Fischer CP, Keller C et al (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285:E433–E437PubMed
16.
go back to reference Moran A, Bundy B, Becker DJ et al (2013) Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381:1905–1915PubMedCrossRef Moran A, Bundy B, Becker DJ et al (2013) Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381:1905–1915PubMedCrossRef
17.
go back to reference Cavelti-Weder C, Babians-Brunner A, Keller C et al (2012) Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35:1654–1662PubMedCentralPubMedCrossRef Cavelti-Weder C, Babians-Brunner A, Keller C et al (2012) Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35:1654–1662PubMedCentralPubMedCrossRef
19.
go back to reference Ben Ounis O, Elloumi M, Lac G et al (2009) Two-month effects of individualized exercise training with or without caloric restriction on plasma adipocytokine levels in obese female adolescents. Ann Endocrinol (Paris) 70:235–241CrossRef Ben Ounis O, Elloumi M, Lac G et al (2009) Two-month effects of individualized exercise training with or without caloric restriction on plasma adipocytokine levels in obese female adolescents. Ann Endocrinol (Paris) 70:235–241CrossRef
20.
go back to reference Pang TTL, Chimen M, Goble E et al (2013) Inhibition of islet immunoreactivity by adiponectin is attenuated in human type 1 diabetes. J Clin Endocrinol Metab 98:E418–E428PubMedCrossRef Pang TTL, Chimen M, Goble E et al (2013) Inhibition of islet immunoreactivity by adiponectin is attenuated in human type 1 diabetes. J Clin Endocrinol Metab 98:E418–E428PubMedCrossRef
21.
go back to reference Oliveira M, Gleeson M (2010) The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men. Eur J Appl Physiol 109:251–257PubMedCrossRef Oliveira M, Gleeson M (2010) The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men. Eur J Appl Physiol 109:251–257PubMedCrossRef
22.
go back to reference Gleeson M, McFarlin B, Flynn M (2006) Exercise and Toll-like receptors. Exerc Immunol Rev 12:34–53PubMed Gleeson M, McFarlin B, Flynn M (2006) Exercise and Toll-like receptors. Exerc Immunol Rev 12:34–53PubMed
23.
go back to reference Karstoft K, Winding K, Knudsen SH et al (2013) The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 36:228–236PubMedCentralPubMedCrossRef Karstoft K, Winding K, Knudsen SH et al (2013) The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 36:228–236PubMedCentralPubMedCrossRef
24.
go back to reference Solomon TPJ, Haus JM, Marchetti CM et al (2009) Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance. Am J Physiol Endocrinol Metab 297:E552–E559PubMedCentralPubMedCrossRef Solomon TPJ, Haus JM, Marchetti CM et al (2009) Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance. Am J Physiol Endocrinol Metab 297:E552–E559PubMedCentralPubMedCrossRef
25.
go back to reference Donath MY, Gross DJ, Cerasi E, Kaiser N (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738–744PubMedCrossRef Donath MY, Gross DJ, Cerasi E, Kaiser N (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738–744PubMedCrossRef
26.
go back to reference Garvey WT, Olefsky JM, Griffin J et al (1985) The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222–234PubMedCrossRef Garvey WT, Olefsky JM, Griffin J et al (1985) The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222–234PubMedCrossRef
27.
go back to reference Hojberg PV, Zander M, Vilsboll T et al (2008) Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes. Diabetologia 51:632–640PubMedCrossRef Hojberg PV, Zander M, Vilsboll T et al (2008) Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes. Diabetologia 51:632–640PubMedCrossRef
28.
go back to reference Paolisso G, Gambardella A, Amato L et al (1995) Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295–1299PubMedCrossRef Paolisso G, Gambardella A, Amato L et al (1995) Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295–1299PubMedCrossRef
29.
go back to reference Elks ML (1993) Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology 133:208–214PubMed Elks ML (1993) Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology 133:208–214PubMed
30.
go back to reference Piro S, Anello M, Di Pietro C et al (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metab Clin Exp 51:1340–1347PubMedCrossRef Piro S, Anello M, Di Pietro C et al (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metab Clin Exp 51:1340–1347PubMedCrossRef
31.
go back to reference Strom A, Kolb H, Martin S et al (2012) Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial). PLoS One 7:e33108PubMedCentralPubMedCrossRef Strom A, Kolb H, Martin S et al (2012) Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial). PLoS One 7:e33108PubMedCentralPubMedCrossRef
32.
go back to reference Coskun O, Ocakci A, Bayraktaroglu T, Kanter M (2004) Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku J Exp Med 203:145–154PubMedCrossRef Coskun O, Ocakci A, Bayraktaroglu T, Kanter M (2004) Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku J Exp Med 203:145–154PubMedCrossRef
33.
go back to reference Huang H-H, Farmer K, Windscheffel J et al (2011) Exercise increases insulin content and basal secretion in pancreatic islets in type 1 diabetic mice. Exp Diabetes Res 2011:481427PubMedCentralPubMed Huang H-H, Farmer K, Windscheffel J et al (2011) Exercise increases insulin content and basal secretion in pancreatic islets in type 1 diabetic mice. Exp Diabetes Res 2011:481427PubMedCentralPubMed
34.
go back to reference Shima K, Zhu M, Noma Y et al (1997) Exercise training in Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus: effects on the B-cell mass, insulin content and fibrosis in the pancreas. Diabetes Res Clin Pract 35:11–19PubMedCrossRef Shima K, Zhu M, Noma Y et al (1997) Exercise training in Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus: effects on the B-cell mass, insulin content and fibrosis in the pancreas. Diabetes Res Clin Pract 35:11–19PubMedCrossRef
35.
go back to reference Pold R, Jensen LS, Jessen N et al (2005) Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54:928–934PubMedCrossRef Pold R, Jensen LS, Jessen N et al (2005) Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54:928–934PubMedCrossRef
36.
go back to reference Király MA, Bates HE, Yue JTY et al (2007) Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise. Metab Clin Exp 56:732–744PubMedCrossRef Király MA, Bates HE, Yue JTY et al (2007) Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise. Metab Clin Exp 56:732–744PubMedCrossRef
37.
go back to reference Király MA, Bates HE, Kaniuk NA et al (2008) Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function. Am J Physiol Endocrinol Metab 294:E271–E283PubMedCrossRef Király MA, Bates HE, Kaniuk NA et al (2008) Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function. Am J Physiol Endocrinol Metab 294:E271–E283PubMedCrossRef
38.
go back to reference Delghingaro-Augusto V, Decary S, Peyot M-L et al (2012) Voluntary running exercise prevents beta-cell failure in susceptible islets of the Zucker diabetic fatty rat. Am J Physiol Endocrinol Metab 302:E254–E264PubMedCrossRef Delghingaro-Augusto V, Decary S, Peyot M-L et al (2012) Voluntary running exercise prevents beta-cell failure in susceptible islets of the Zucker diabetic fatty rat. Am J Physiol Endocrinol Metab 302:E254–E264PubMedCrossRef
39.
go back to reference Laker RC, Gallo LA, Wlodek ME et al (2011) Short-term exercise training early in life restores deficits in pancreatic beta-cell mass associated with growth restriction in adult male rats. Am J Physiol Endocrinol Metab 301:E931–E940PubMedCrossRef Laker RC, Gallo LA, Wlodek ME et al (2011) Short-term exercise training early in life restores deficits in pancreatic beta-cell mass associated with growth restriction in adult male rats. Am J Physiol Endocrinol Metab 301:E931–E940PubMedCrossRef
40.
go back to reference Kruszynska YT, Home PD, Hanning I, Alberti KG (1987) Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia 30:16–21PubMedCrossRef Kruszynska YT, Home PD, Hanning I, Alberti KG (1987) Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia 30:16–21PubMedCrossRef
41.
go back to reference Palmer JP, Fleming GA, Greenbaum CJ et al (2004) C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 53:250–264PubMedCrossRef Palmer JP, Fleming GA, Greenbaum CJ et al (2004) C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 53:250–264PubMedCrossRef
42.
go back to reference Retnakaran R, Qi Y, Goran MI, Hamilton JK (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26:1198–1203PubMedCrossRef Retnakaran R, Qi Y, Goran MI, Hamilton JK (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26:1198–1203PubMedCrossRef
43.
go back to reference Dalla Man C, Campioni M, Polonsky KS et al (2005) Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 54:3265–3273PubMedCrossRef Dalla Man C, Campioni M, Polonsky KS et al (2005) Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 54:3265–3273PubMedCrossRef
44.
45.
go back to reference Boule NG, Weisnagel SJ, Lakka TA et al (2005) Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care 28:108–114PubMedCrossRef Boule NG, Weisnagel SJ, Lakka TA et al (2005) Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care 28:108–114PubMedCrossRef
46.
go back to reference Bloem CJ, Chang AM (2008) Short-term exercise improves beta-cell function and insulin resistance in older people with impaired glucose tolerance. J Clin Endocrinol Metab 93:387–392PubMedCentralPubMedCrossRef Bloem CJ, Chang AM (2008) Short-term exercise improves beta-cell function and insulin resistance in older people with impaired glucose tolerance. J Clin Endocrinol Metab 93:387–392PubMedCentralPubMedCrossRef
47.
go back to reference Malin SK, Solomon TPJ, Blaszczak A et al (2013) Pancreatic beta-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes. Am J Physiol Endocrinol Metab 305:E1248–E1254PubMedCentralPubMedCrossRef Malin SK, Solomon TPJ, Blaszczak A et al (2013) Pancreatic beta-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes. Am J Physiol Endocrinol Metab 305:E1248–E1254PubMedCentralPubMedCrossRef
48.
go back to reference Reitman JS, Vasquez B, Klimes I, Nagulesparan M (1984) Improvement of glucose homeostasis after exercise training in non-insulin-dependent diabetes. Diabetes Care 7:434–441PubMedCrossRef Reitman JS, Vasquez B, Klimes I, Nagulesparan M (1984) Improvement of glucose homeostasis after exercise training in non-insulin-dependent diabetes. Diabetes Care 7:434–441PubMedCrossRef
49.
go back to reference Krotkiewski M, Lonnroth P, Mandroukas K et al (1985) The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 28:881–890PubMedCrossRef Krotkiewski M, Lonnroth P, Mandroukas K et al (1985) The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 28:881–890PubMedCrossRef
50.
go back to reference Trovati M, Carta Q, Cavalot F et al (1984) Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 7:416–420PubMedCrossRef Trovati M, Carta Q, Cavalot F et al (1984) Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 7:416–420PubMedCrossRef
51.
go back to reference Michishita R, Shono N, Kasahara T, Tsuruta T (2008) Effects of low intensity exercise therapy on early phase insulin secretion in overweight subjects with impaired glucose tolerance and type 2 diabetes mellitus. Diabetes Res Clin Pract 82:291–297PubMedCrossRef Michishita R, Shono N, Kasahara T, Tsuruta T (2008) Effects of low intensity exercise therapy on early phase insulin secretion in overweight subjects with impaired glucose tolerance and type 2 diabetes mellitus. Diabetes Res Clin Pract 82:291–297PubMedCrossRef
52.
go back to reference Solomon TPJ, Haus JM, Kelly KR et al (2010) Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 33:1561–1566PubMedCentralPubMedCrossRef Solomon TPJ, Haus JM, Kelly KR et al (2010) Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 33:1561–1566PubMedCentralPubMedCrossRef
53.
go back to reference Dela F, von Linstow ME, Mikines KJ, Galbo H (2004) Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 287:E1024–E1031PubMedCrossRef Dela F, von Linstow ME, Mikines KJ, Galbo H (2004) Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 287:E1024–E1031PubMedCrossRef
54.
go back to reference Solomon TPJ, Malin SK, Karstoft K et al (2013) Pancreatic beta-cell function is a stronger predictor of changes in glycemic control after an aerobic exercise intervention than insulin sensitivity. J Clin Endocrinol Metab 98:4176–4186PubMedCentralPubMedCrossRef Solomon TPJ, Malin SK, Karstoft K et al (2013) Pancreatic beta-cell function is a stronger predictor of changes in glycemic control after an aerobic exercise intervention than insulin sensitivity. J Clin Endocrinol Metab 98:4176–4186PubMedCentralPubMedCrossRef
55.
go back to reference Kahleova H, Mari A, Nofrate V et al (2012) Improvement in beta-cell function after diet-induced weight loss is associated with decrease in pancreatic polypeptide in subjects with type 2 diabetes. J Diabetes Complications 26:442–449PubMedCrossRef Kahleova H, Mari A, Nofrate V et al (2012) Improvement in beta-cell function after diet-induced weight loss is associated with decrease in pancreatic polypeptide in subjects with type 2 diabetes. J Diabetes Complications 26:442–449PubMedCrossRef
56.
go back to reference Burns N, Finucane FM, Hatunic M et al (2007) Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 50:1500–1508PubMedCrossRef Burns N, Finucane FM, Hatunic M et al (2007) Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 50:1500–1508PubMedCrossRef
57.
go back to reference Dabelea D, Mayer-Davis EJ, Andrews JS et al (2012) Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 55:3359–3368PubMedCrossRef Dabelea D, Mayer-Davis EJ, Andrews JS et al (2012) Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 55:3359–3368PubMedCrossRef
58.
go back to reference Maclaren N, Lan M, Coutant R et al (1999) Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (type 1) diabetes in relatives. J Autoimmun 12:279–287PubMedCrossRef Maclaren N, Lan M, Coutant R et al (1999) Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (type 1) diabetes in relatives. J Autoimmun 12:279–287PubMedCrossRef
59.
go back to reference Cutovic M, Konstantinovic L, Stankovic Z, Vesovic-Potic V (2012) Structured exercise program improves functional capacity and delays relapse in euthyroid patients with Graves’ disease. Disabil Rehabil 34:1511–1518PubMedCrossRef Cutovic M, Konstantinovic L, Stankovic Z, Vesovic-Potic V (2012) Structured exercise program improves functional capacity and delays relapse in euthyroid patients with Graves’ disease. Disabil Rehabil 34:1511–1518PubMedCrossRef
60.
go back to reference Naldi L, Conti A, Cazzaniga S et al (2014) Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol 170:634–642PubMedCrossRef Naldi L, Conti A, Cazzaniga S et al (2014) Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol 170:634–642PubMedCrossRef
61.
go back to reference Dalgas U, Stenager E (2012) Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis? Ther Adv Neurol Disord 5:81–95PubMedCentralPubMedCrossRef Dalgas U, Stenager E (2012) Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis? Ther Adv Neurol Disord 5:81–95PubMedCentralPubMedCrossRef
62.
go back to reference Chimen M, Kennedy A, Nirantharakumar K et al (2012) What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 55:542–551PubMedCrossRef Chimen M, Kennedy A, Nirantharakumar K et al (2012) What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 55:542–551PubMedCrossRef
63.
go back to reference Galassetti P, Riddell MC (2013) Exercise and type 1 diabetes (T1DM). Compr Physiol 3:1309–1336PubMed Galassetti P, Riddell MC (2013) Exercise and type 1 diabetes (T1DM). Compr Physiol 3:1309–1336PubMed
64.
go back to reference Tielemans SMAJ, Soedamah-Muthu SS, de Neve M et al (2013) Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia 56:82–91PubMedCrossRef Tielemans SMAJ, Soedamah-Muthu SS, de Neve M et al (2013) Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia 56:82–91PubMedCrossRef
65.
go back to reference Brazeau A-S, Rabasa-Lhoret R, Strychar I, Mircescu H (2008) Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 31:2108–2109PubMedCentralPubMedCrossRef Brazeau A-S, Rabasa-Lhoret R, Strychar I, Mircescu H (2008) Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 31:2108–2109PubMedCentralPubMedCrossRef
66.
go back to reference Kahn SE, Larson VG, Beard JC et al (1990) Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am J Physiol 258:E937–E943PubMed Kahn SE, Larson VG, Beard JC et al (1990) Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am J Physiol 258:E937–E943PubMed
67.
go back to reference Pratley RE, Hagberg JM, Dengel DR et al (2000) Aerobic exercise training-induced reductions in abdominal fat and glucose-stimulated insulin responses in middle-aged and older men. J Am Geriatr Soc 48:1055–1061PubMed Pratley RE, Hagberg JM, Dengel DR et al (2000) Aerobic exercise training-induced reductions in abdominal fat and glucose-stimulated insulin responses in middle-aged and older men. J Am Geriatr Soc 48:1055–1061PubMed
68.
go back to reference Dela F, Stallknecht B (2010) Effect of physical training on insulin secretion and action in skeletal muscle and adipose tissue of first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 299:E80–E91PubMedCrossRef Dela F, Stallknecht B (2010) Effect of physical training on insulin secretion and action in skeletal muscle and adipose tissue of first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 299:E80–E91PubMedCrossRef
Metadata
Title
The time has come to test the beta cell preserving effects of exercise in patients with new onset type 1 diabetes
Authors
Parth Narendran
Thomas P. Solomon
Amy Kennedy
Myriam Chimen
Rob C. Andrews
Publication date
01-01-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3412-8

Other articles of this Issue 1/2015

Diabetologia 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.